Literature DB >> 24621470

Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes.

Hiroshi Kusunoki1, Yoshiaki Taniyama1, Rei Otsu2, Hiromi Rakugi3, Ryuichi Morishita2.   

Abstract

The paracrine loop involving inflammatory cytokines between adipocytes and macrophages establishes a vicious cycle that aggravates pro-inflammatory changes in adipose tissue. The serum level of hepatocyte growth factor (HGF) is increased in metabolic syndrome, but whether HGF is beneficial or detrimental in inflammatory conditions is unclear. We previously reported that HGF has strong anti-inflammatory effects. We therefore hypothesized that HGF may inhibit chronic inflammation in adipose tissue by inhibiting the vicious cycle between adipocytes and macrophages. We stimulated the macrophage cell line RAW264 with HGF and evaluated pro-inflammatory cytokines. Coculturing differentiated 3T3-L1 adipocytes with RAW264 results in marked upregulation of pro-inflammatory cytokines. We examined whether HGF suppresses the upregulation of pro-inflammatory cytokines in this coculture system. Cardiac-specific HGF transgenic mice (HGF-Tg) were crossed with ApoE KO (knockout) mice, to yield ApoE KO/HGF-Tg mice, which were treated with a high-fat diet (HFD) and received angiotensin (Ang) II. The phenotypes of ApoE KO and ApoE KO/HGF-Tg mice were compared. Treatment with HGF reduced the expression of pro-inflammatory cytokine genes (Tumor necrosis factor-α, monocyte chemoattractant protein-1 and interleukin-6) in RAW264 and the coculture system. The anti-inflammatory effects of HGF were also confirmed in in vivo studies. Macrophage infiltration in epididymal adipose and fatty liver was reduced in ApoE KO/HGF-Tg. Adipocyte diameter was reduced in ApoE KO/HGF-Tg, and the serum adiponectin level was upregulated. These beneficial effects in ApoE KO/HGF-Tg mice under HFD and Ang II infusion were abrogated by an anti-HGF neutralizing antibody. These results suggest that HGF inhibits the vicious cycle of adipocytes and macrophages through the inhibition of macrophage-mediated pro-inflammatory cytokines and upregulation of adiponectin in adipocytes. These favorable effects may suppress chronic inflammation in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24621470     DOI: 10.1038/hr.2014.41

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  19 in total

1.  Elevated circulating sST2 associated with subclinical atherosclerosis in newly diagnosed primary hypertension.

Authors:  Ihsan Ates; Nihal Ozkayar; Hale Ates; Uğur Nadir Karakulak; Oğuzhan Kursun; Canan Topcuoglu; Bayram Inan; Nisbet Yilmaz
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

2.  Hepatocyte Growth Factor Suppresses Inflammation and Promotes Epithelium Repair in Corneal Injury.

Authors:  Masahiro Omoto; Kunal Suri; Afsaneh Amouzegar; Mingshun Li; Kishore R Katikireddy; Sharad K Mittal; Sunil K Chauhan
Journal:  Mol Ther       Date:  2017-05-11       Impact factor: 11.454

3.  In vitro evaluation of anti-fibrotic effects of select cytokines for vocal fold scar treatment.

Authors:  Hongyu Chen; Josh Erndt-Marino; Patricia Diaz-Rodriguez; Jonathan Kulwatno; Andrea C Jimenez-Vergara; Susan L Thibeault; Mariah S Hahn
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2018-09-05       Impact factor: 3.368

4.  Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition.

Authors:  Lauren A Biwer; Karen M D'souza; Ali Abidali; Danni Tu; Ashley L Siniard; Matthew DeBoth; Matthew Huentelman; Taben M Hale
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

5.  Hepatoma-derived growth factor upregulation is correlated with prognostic factors of early-stage cervical adenocarcinoma.

Authors:  Ching-Chou Tsai; Shun-Chen Huang; Ming Hong Tai; Chan-Chao Chang Chien; Chao-Cheng Huang; Yi-Chiang Hsu
Journal:  Int J Mol Sci       Date:  2014-11-21       Impact factor: 5.923

Review 6.  The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?

Authors:  Marjorie Boissinot; Mathias Vilaine; Sylvie Hermouet
Journal:  Cancers (Basel)       Date:  2014-08-12       Impact factor: 6.639

7.  Combinations of bio-active dietary constituents affect human white adipocyte function in-vitro.

Authors:  Ines Warnke; Johan W E Jocken; Rotraut Schoop; Christine Toepfer; Regina Goralczyk; Joseph Schwager
Journal:  Nutr Metab (Lond)       Date:  2016-11-21       Impact factor: 4.169

8.  Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.

Authors:  Jun Muratsu; Masaaki Iwabayashi; Fumihiro Sanada; Yoshiaki Taniyama; Rei Otsu; Hiromi Rakugi; Ryuichi Morishita
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

9.  Specific Strains of Lactic Acid Bacteria Differentially Modulate the Profile of Adipokines In Vitro.

Authors:  Emanuel Fabersani; María Claudia Abeijon-Mukdsi; Romina Ross; Roxana Medina; Silvia González; Paola Gauffin-Cano
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

10.  HGF can reduce accumulation of inflammation and regulate glucose homeostasis in T2D mice.

Authors:  Liting Yan; Xiaoxi He; Yinghua Tang; Xiaomin Zhao; Gang Luo; Xinhong Wang
Journal:  J Physiol Biochem       Date:  2021-08-07       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.